{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:58:34Z","timestamp":1789397914351,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jhep.2013.04.014","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T10:13:25Z","timestamp":1366712005000},"page":"318-326","source":"Crossref","is-referenced-by-count":109,"title":["Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model"],"prefix":"10.1016","volume":"59","author":[{"given":"S.M.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vasilaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.04.014_b0005","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(11)60613-2","article-title":"Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial","volume":"377","author":"Maughan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2013.04.014_b0010","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.014_b0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2013.04.014_b0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.surg.2009.01.004","article-title":"Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases","volume":"147","author":"Hubert","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2013.04.014_b0025","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2013.04.014_b0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","article-title":"Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy","volume":"18","author":"Tamandl","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.jhep.2013.04.014_b0035","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","article-title":"Chemotherapy associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis","volume":"19","author":"Robinson","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2013.04.014_b0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00428-007-0497-1","article-title":"The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study","volume":"451","author":"Aloysius","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhep.2013.04.014_b0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2013.04.014_b0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.jhep.2013.04.014_b0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2559.2012.04208.x","article-title":"Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases","volume":"61","author":"Vreuls","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jhep.2013.04.014_b0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/cncr.24710","article-title":"An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate","volume":"116","author":"Keizman","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2013.04.014_b0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jnci\/88.7.430","article-title":"Role of fluoropyrimidine Schedule and (6R, S)leucovorin dose in a preclinical animal model of colorectal carcinoma","volume":"88","author":"Cao","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2013.04.014_b0070","first-page":"3362","article-title":"Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in mice","volume":"49","author":"Boughattas","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2013.04.014_b0075","series-title":"Free radicals, a practical approach","first-page":"213","article-title":"Measurement of antioxidants: glutathione","author":"Anderson","year":"1996"},{"key":"10.1016\/j.jhep.2013.04.014_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.04.014_b0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2013.04.014_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Collado","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.04.014_b0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","article-title":"Gene expression profiling provides insights into pathways of oxaliplatin related sinusoidal obstruction syndrome in humans","volume":"10","author":"Rubbia-Brandt","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2013.04.014_b0100","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4161\/cc.5.23.3510","article-title":"Senescence, wound healing and cancer: the PAI-1 connection","volume":"5","author":"Kortlever","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jhep.2013.04.014_b0105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb1448","article-title":"Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence","volume":"8","author":"Kortlever","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jhep.2013.04.014_b0110","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1093\/nar\/gkm744","article-title":"Two faces of p53: aging and tumor suppression","volume":"35","author":"Rodier","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2013.04.014_b0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0609.1997.tb00985.x","article-title":"Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver","volume":"59","author":"Remberger","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jhep.2013.04.014_b0120","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","article-title":"Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network","volume":"133","author":"Kuilman","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.04.014_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2009.08.003","article-title":"Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration","volume":"34","author":"Drucker","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2013.04.014_b0130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jhep.2013.04.014_b0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2004.12.006","article-title":"Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy","volume":"31","author":"Kweekel","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jhep.2013.04.014_b0140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.510310224","article-title":"Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat","volume":"31","author":"Wang","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.014_b0145","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/carcin\/22.9.1373","article-title":"Dietary N-acetyl-l-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice","volume":"22","author":"Martin","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2013.04.014_b0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/03602532.2011.567391","article-title":"Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents","volume":"43","author":"Higgins","year":"2011","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhep.2013.04.014_b0250","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2012.07.004","article-title":"Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9","volume":"57","author":"Nakamura","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.014_b0160","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2013.04.014_b0165","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2013 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.04.014_b0170","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.014_b0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10937409809524557","article-title":"Chronic pulmonary hypertension \u2013 the monocrotaline model and involvement of the hemostatic system","volume":"1","author":"Schultze","year":"1998","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.jhep.2013.04.014_b0180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-1-4684-5877-0_64","article-title":"Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite","volume":"283","author":"Roth","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jhep.2013.04.014_b0185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.mehy.2008.07.045","article-title":"Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells","volume":"72","author":"McCarty","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jhep.2013.04.014_b0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jn\/134.3.522","article-title":"Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats","volume":"134","author":"Ascencio","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.jhep.2013.04.014_b0255","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jhep.2013.04.014_b0260","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.04.014_b0205","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1042\/bj20021619","article-title":"Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element","volume":"371","author":"Balogun","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2013.04.014_b0210","first-page":"319","article-title":"Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R","volume":"30","author":"Patel","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jhep.2013.04.014_b0215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2013.04.014_b0220","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1182\/blood-2008-04-149682","article-title":"Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease","volume":"112","author":"Benimetskaya","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.04.014_b0225","first-page":"2550","article-title":"Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury","volume":"119","author":"Scotton","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.04.014_b0230","doi-asserted-by":"crossref","first-page":"G226","DOI":"10.1152\/ajpgi.00444.2007","article-title":"Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis","volume":"294","author":"Rullier","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2013.04.014_b0235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.04.014_b0265","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jhep.2011.10.023","article-title":"Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation","volume":"56","author":"Agostini","year":"2012","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813002675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813002675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T11:28:25Z","timestamp":1715254105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813002675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0168827813002675"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.04.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}